Abstract:Introduction: Functional disorder of the placenta is the principal cause of fetal growth restriction (FGR), usually cured with suitable clinical treatment and good nursing. However, some FGR mothers still give birth to small for gestational age (SGA) babies after treatment. The ineffectiveness of treatment in such a group of patients confused physicians of obstetrics and gynecology. Methods: In this study, we performed a microRNA-messenger RNA integrative analysis of gene expression profiles obtained from Gene Expression Omnibus. Differentially expressed genes were screened and checked using quantitative polymerase chain reaction. Target genes of significantly changed microRNA were screened and enriched for Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway analyses. Function of the obtained microRNA-messenger RNA was evaluated using HTR-8/SVneo trophoblast cells, human umbilical vein endothelial cells, and heterozygote male mice. Result: MiR-155-5p was upregulated ( p = 0.001, fold-change = 2.275) in fetal-side placentals. Among the hub genes identified as key targets for miR-155-5p in fetal reprogramming, Smad2 was downregulated ( p = 0.002, fold change = 0.426) and negatively correlated with miR-155-5p expression levels (r = −0.471, p < 1.0 E – 04) in fetal-side placental tissues. The miR-155-5p mimic blocks Smad2 expression and suppresses villous trophoblast cell and endothelial cell function (proliferation, migration, and invasion), indicating a close relationship with placental development. Luciferase assays further confirmed the targeting of miR-155-5p to Smad2. Furthermore, Smad2 +/− heterozygote male mice were born small with low body weight ( p = 0.0281) and fat composition ( p = 0.013) in the fourth week post-natal. Discussion: We provide the first evidence of the role of the Smad2/miR-155-5p axis in the placental pathologies of FGR. Our findings elucidate the pathogenesis of FGR and provide new therapeutic targets.

Placental Expression of Human Histocompatibility Antigen-G Mrna in Idiopathic Fetal Growth Restriction and Its Relationship with Pathological Changes of Placenta

Galectin-1 Expression in the Serum and Placenta of Pregnant Women with Fetal Growth Restriction and Its Significance

The Expression of Inhibin α,Follistatin in Placenta and Their Relationship to FGR

Expression of human leukocyte antigen-G during normal placentation and in preeclamptic pregnancies.

[Expression of Human Leucocyte Antigen G on Human Placenta and Its Gene Polymorphism in Relation to Intrahepatic Cholestasis of Pregnancy].

Analysis of Placental Growth Factor in Placentas of Normal Pregnant Women and Women with Hypertensive Disorders of Pregnancy

Expression and Its Clinical Significance of HLA-G in HCMV-infected Placental Villi at Early Pregnant Stage

The placental blood perfusion and LINC00473-mediated promotion of trophoblast apoptosis in fetal growth restriction

Expression of Placental Vascular Growth Factor in Pregnancy-Induced Hypertension

An miRNA-mRNA integrative analysis in human placentas and mice: role of the Smad2/miR-155-5p axis in the development of fetal growth restriction

FGR-associated Placental Insufficiency and Capillary Angiogenesis Involves Disruptions in Human Placental Mirnas and Mrnas

Expression of Various Subtypes of HLA-G Mrna in Placentas of Pregnant Women Complicated with Severe Preeclampsia

The Placental Pathology and Immune Factors of Idiopathic Intrauterine Growth Retardation

Integrated Analysis of Key Genes and Pathways Involved in Fetal Growth Restriction and Their Associations With the Dysregulation of the Maternal Immune System

The expression of HLA-G Mrna isoforms in placentas from women with preeclampsia and normal pregnancy

Relationship Between Expression of Vimentin, Type IV Collagen and Fibronectin in Human Placenta and Pregnancy Induced Hypertension

[Role of Placental Apoptosis in Fetal Growth Restriction].

Immunohistochemical localization of HCA1 receptor in placenta in presence of fetal growth restriction

Integrated Bioinformatics Analysis to Screen Hub Gene Signatures for Fetal Growth Restriction

MicroRNA Expression Profiles and Networks in Placentas Complicated with Selective Intrauterine Growth Restriction.

[Relationship Between Placenta Growth Factor and the Pathogenesis of Pregnancy Induced Hypertension Syndrome].